HEALTHCARE TRANSACTION ADVISORY
Expert M&A Advisory to Maximize Value Creation
Command the entire deal continuum—from initial due diligence and cash flow modeling to deal structuring and final closing.
Validating Financial Realities to Safeguard Investments
Healthcare transactions operate in a highly scrutinized environment that demands precision from investors and regulators alike. Succeeding in this landscape allows organizations to maximize enterprise value, ensure compliance, and execute seamless strategic transactions.
VMG Health provides end-to-end transaction advisory for both sellers and buyers, equipping your leadership team with the rigorous process and objective third-party oversight needed for optimal outcomes.
For sellers, we identify hidden value drivers and perform the pre-deal diligence necessary to ensure a smooth execution. By objectively evaluating your quality of earnings and historical performance, we equip your corporate development team, board, and sponsors with the empirical data required to command the negotiating table.
Definitive Guidance for a Successful Exit
Preparing a healthcare asset for the market requires proactive strategy to maximize enterprise value and survive arduous buyer scrutiny. We guide sellers through the entire transaction process, providing the senior-level advisory required to get your house in order before engaging interested parties.
Step
Prepare for Sale
Proactively evaluate your financials and operations to resolve vulnerabilities before they impact your valuation.
Step
Market Your Asset
Develop a comprehensive Confidential Information Memorandum (CIM) and systematically find and evaluate interested buyers who align with your strategic goals.
Step
Navigate Due Diligence
Support your team through the diligence process, leveraging our extensive transaction experience, so you know exactly what is normal and what to expect at every milestone.
Step
Optimize Deal Terms
Deliver expert transaction advisory to help you negotiate from a position of strength and secure the best possible agreement.
Step
Step
Step
Step
Step
Strategic Solutions for Sellers, Investors & C-Suites
Transaction Advisory Experts
Kevin McDonough, CFA
Head of Valuation & Transaction Advisory Services
John Poziemski
Head of Strategy & Partnership Advisory
Don Barbo, CPA/ABV
Managing Director
Clinton Flume, CVA
Managing Director
Colin McDermott, CFA, CPA/ABV
Managing Director
Aaron Murski, CVA
Managing Director
Colin Park, CPA/ABV, ASA
Managing Director
Lukas Recio, CPA
Managing Director
Joe Scott, CPA
Managing Director
Chance Sherer, CVA
Managing Director
Todd J. Sorensen, CVA
Managing Director
Chad Zoretic, CEPA
Managing Director & Partnerships, Mergers & Acquisitions Practice Leader
Hear From VMG Health Transaction Advisory Clients
Actionable Intelligence for Healthcare Dealmakers
Bring exact financial frameworks, predictive data, and transaction intelligence to your deal team, designed by and for healthcare investors.
PACE Capitation Meets For-Profit Capital
Since 1971, the Program of All-Inclusive Care for the Elderly (PACE) has operated as one of healthcare’s most effective yet least scaled models. Created to keep nursing home–eligible seniors in their own homes, PACE combines full clinical responsibility with full financial risk. Historically, the…
June 25, 2026
Scaling Cardiology: How Site-of-Care Strategy Is Reshaping M&A
Cardiology transaction activity remains strong, but the underlying investment strategy has evolved significantly over the last several years. Historically, many
Read More
June 10, 2026
When Valuation Formulas & Internally Prepared Valuations Become Compliance Risks
In 2025, civil fraud recoveries reached record levels, primarily driven by healthcare–related qui tam lawsuits. As the Department of Justice
Read More
June 9, 2026
The Next Phase of DSO Consolidation: Opportunity Still Exists, but Expectations Have Changed
The dental service organization (DSO) market remains active, but the environment surrounding transactions has become significantly more disciplined than it
Read More
May 21, 2026
Pharmacy M&A in Transition: Key Trends Shaping 2026
The pharmacy services sector saw substantial M&A activity between June 2025 and May 2026, as private equity firms continued to
Read More
March 11, 2026
From Policy to Profit: The Biggest Takeaways from Healthcare’s Q4 2025 Earnings Season
As Q4 2025 earnings season wraps up, VMG Health observed some key themes from the publicly traded payers’ and hospital
Read More
March 10, 2026
Scaling DSOs: Why Integration & Liquidity Planning Matter Now
Dental service organizations are no longer an emerging model: They are a permanent and expanding part of the dental landscape.
Read More
March 9, 2026
Healthcare M&A: 2025 Trends and 2026 Outlook
Drawing on findings from VMG Health’s 2026 Healthcare M&A Report, this webinar will highlight how buyers and operators are adapting
Read More
March 2, 2026
2026 Healthcare M&A Report
Your Annual M&A Strategy Starts Here: VMG Health’s 2026 Healthcare M&A Report The 2025 healthcare M&A market reflected the impact
Read More
February 12, 2026
Why Quality of Revenue Matters More Than EBITDA in DSO Strategy
EBITDA Is Only the Beginning In dental service organizations (DSOs), EBITDA often dominates conversations about growth, performance, and valuation, but
Read MoreTransaction Advisory Frequently Asked Questions
Frequently Asked Questions
What does VMG Health’s financial due diligence include?
We deeply analyze historical statements, validate revenue streams, evaluate underlying run-rate earnings, and scrutinize tax treatments to expose critical vulnerabilities and provide definitive QoE insights. As part of our comprehensive transaction advisory services, we deliver the empirical financial data required to de-risk acquisitions and validate enterprise value.
How does VMG Health support both buy-side and sell-side transactions?
We deliver tailored buy-side advisory for private equity sponsors and health systems seeking to evaluate target entities and validate earnings quality. For sellers, our sell-side advisory prepares clinical assets for market, identifying hidden value drivers and performing pre-deal diligence to ensure a smooth execution.
How does VMG Health differ from traditional healthcare investment banking firms?
Unlike traditional healthcare investment banking firms that operate primarily as brokers, VMG Health provides objective, healthcare-exclusive advisory backed by 30 years of valuation mastery. We focus on objectivity and due diligence rather than just pushing a deal to close.
What should I consider if I am looking to sell my medical practice?
If you are preparing to sell a medical practice or transition to a larger health system, establishing an accurate, defensible valuation and evaluating billing compliance are essential first steps. We guide physician owners through practice readiness, ensuring your historical earnings and clinical documentation stand up to institutional investor scrutiny.
Maximize Your Exit Value & Protect Your Acquisitions
Whether you are preparing a healthcare asset for a strategic sale or executing rigorous buy-side due diligence to protect your capital, partner with VMG Health for expert transaction advisory services.
Speak to an Expert